Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Surrozen, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +5 vs. Q1 2024
- Shares held
- 2.11M
- +1.15M (+119.9%) vs. Q1 2024
- Total value
- $23.1M
- +$8.06M (+53.7%) vs. Q1 2024
- New holders
- 8
- 5 more added
- Sold out
- 3
- 2 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The Column Group LLC | 810,088 | $8.87M | 12.44% | +193,548+31.4% | Added |
| Ra Capital Management, L.P. | 282,580 | $3.09M | 0.04% | +282,580 | New |
| Armistice Capital, LLC | 190,000 | $2.08M | 0.05% | +190,000 | New |
| Nantahala Capital Management, LLC | 187,206 | $2.05M | 0.21% | +187,206 | New |
| StemPoint Capital LP | 143,510 | $1.57M | 0.46% | +143,510 | New |
| Euclidean Capital LLC | 87,696 | $960.3K | 0.12% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 66,084 | $723.6K | 0.66% | +66,084 | New |
| CVI Holdings, LLC | 64,905 | $710.7K | 0.61% | +64,905 | New |
| Vanguard Group Inc | 60,835 | $666.1K | 0.00% | â676â1.1% | Reduced |
| ArrowMark Colorado Holdings LLC | 55,123 | $603.6K | 0.01% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 52,130 | $570.8K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 35,211 | $385.6K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 20,376 | $223.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,708 | $204.9K | 0.00% | +7,235+63.1% | Added |
| Renaissance Technologies LLC | 12,426 | $136.1K | 0.00% | â1,300â9.5% | Reduced |
| UBS Group AG | 12,027 | $131.7K | 0.00% | +12,027 | New |
| BlackRock Inc. | 5,679 | $62.2K | 0.00% | +3,267+135.4% | Added |
| Royal Bank of Canada | 338 | $4.00K | 0.00% | +180+113.9% | Added |
| Wolverine Asset Management LLC | 281 | $3.08K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 20 | $219 | 0.00% | +20 | New |
| JPMorgan Chase & Co | 7 | $77 | 0.00% | +4+133.3% | Added |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | â450â100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | â184â100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | â10â100.0% | Sold out |